FRESENIUS MEDICAL CARE AG &/ DE0005785802 /

8/12/2022 5:29:36 PM	Chg. -0.32	Volume	Bid5:30:11 AM	Ask5:30:11 AM	Market Capitalization	Dividend Y.	P/E Ratio
36.69EUR	-0.86%	23,144 Turnover: 854,347.65	-Bid Size: -	-Ask Size: -	10.79 bill.EUR	3.67%	11.12

GlobeNewswire 3/29 Humacyte Reports Fourth Quarter and Year End 2021 Financial Results and Provides Business Update

TeleTrader 3/25 Europe closes mostly higher after US, EU energy deal

GlobeNewswire 2/25 Kapruvia® receives positive CHMP opinion for the treatment of moderate-to-severe pruritus in hemodia...

GlobeNewswire 2/24 Dentsply Sirona Announces Appointment of Dr. Dorothea Wenzel as New Board Member

GlobeNewswire 2/3 RAYALDEE® Launched in Germany by OPKO Health’s Licensee, VFMCRP

TeleTrader 1/25 Europe shrugs off global turmoil, ends higher

TeleTrader 1/17 Europe ends higher after upbeat Chinese data

TeleTrader 1/17 Europe opens higher amid the Forum, COVID data

GlobeNewswire 12/31/2021 CIO Leadership: HMG Strategy, the World’s #1 Executive Leadership Network, Looks Ahead to its 15th Y...

GlobeNewswire 12/9/2021 Angion and Vifor Pharma Report Topline Results from Phase 2 GUARD Trial of ANG-3777 in Cardiac Surge...

GlobeNewswire 11/22/2021 Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology

GlobeNewswire 11/12/2021 Humacyte Reports Third Quarter 2021 Financial Results and Provides Business Highlights

TeleTrader 11/9/2021 Europe opens lower with data, earnings in focus

GlobeNewswire 11/8/2021 Cara Therapeutics Reports Third Quarter 2021 Financial Results

GlobeNewswire 10/27/2021 CIO Leadership: Exemplifying Authentic Leadership and Leveraging Personal Branding to Act as a Globa...

GlobeNewswire 10/26/2021 Angion and Vifor Pharma Report Topline Results from Phase 3 Trial of ANG-3777 in Kidney Transplant P...

GlobeNewswire 9/15/2021 Travere Therapeutics and Vifor Pharma Announce Licensing Agreement for the Commercialization of Spar...

TeleTrader 9/10/2021 Europe closes mixed on COVID-19 concerns

GlobeNewswire 8/26/2021 Humacyte Announces Successful Closing of Business Combination with Alpha Healthcare Acquisition Corp...

GlobeNewswire 8/23/2021 Cara Therapeutics and Vifor Pharma announce U.S. FDA approval of KORSUVA™ (difelikefalin) injection ...

TeleTrader 7/30/2021 Europe closes lower after data, earnings

GlobeNewswire 6/11/2021 UPDATE -- Humacyte Expands Strategic Global Partnership with Fresenius Medical Care

GlobeNewswire 6/11/2021 Humacyte Expands Strategic Global Partnership with Fresenius Medical Care

GlobeNewswire 5/24/2021 OPKO Health Reports Transfer of Licensed Rights to RAYALDEE® in Japan to Vifor